Jackson Square Capital, LLC Dynavax Technologies Corp Transaction History
Jackson Square Capital, LLC
- $383 Million
- Q4 2024
A detailed history of Jackson Square Capital, LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Jackson Square Capital, LLC holds 40,584 shares of DVAX stock, worth $560,870. This represents 0.14% of its overall portfolio holdings.
Number of Shares
40,584
Previous 40,584
-0.0%
Holding current value
$560,870
Previous $452,000
14.6%
% of portfolio
0.14%
Previous 0.12%
Shares
8 transactions
Others Institutions Holding DVAX
# of Institutions
288Shares Held
131MCall Options Held
507KPut Options Held
374K-
Black Rock Inc. New York, NY21.9MShares$303 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT17.8MShares$246 Million10.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.16MShares$127 Million0.0% of portfolio
-
State Street Corp Boston, MA7.79MShares$108 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ6.56MShares$90.7 Million5.31% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.75B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...